|apersy|

Value | Market Access | Commercialisation

This news update has a bit of a theme: HTA and reimbursement policies. There are a few reforms and regulation changes on-going across European markets, not to forget the preparations for the joint European HTA efforts through the Joint Clinical Assessment.

Take three minutes to get on top of the latest updates.

Other recent posts: